Agilent Technologies Stock Surges 9.3%, With A 5-Day Winning Spree
Agilent Technologies (A) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 9.3% return. The company has gained about $3.8 Bil in value over the last 5 days, with its current market capitalization at about $45 Bil. The stock remains 17.7% above its value at the end of 2024. This compares with year-to-date returns of 15% for the S&P 500.
Agilent Technologies’ recent streak reflects investor enthusiasm for its robust Q4 2025 earnings beat and an upwardly revised 2026 revenue outlook of $7.3-7.4 billion. This powerful combination of strong operational execution and confident guidance has fueled analyst upgrades, underscoring the company’s solid footing in the life sciences sector.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There are only a couple of things to fear in Agilent Technologies stock given its overall Moderate operating performance and financial condition. But keeping in mind its Very High valuation, we think that the stock is Unattractive (see Buy or Sell A).
For quick background, A provides application-focused solutions for life sciences, diagnostics, and applied chemical markets, including liquid chromatography systems, DNA mutation detection, genotyping, sequencing, and genetic data management.
Comparing A Stock Returns With The S&P 500
The following table summarizes the return for A stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | A | S&P 500 |
|---|---|---|
| 1D | 2.3% | 0.9% |
| 5D (Current Streak) | 9.3% | 2.2% |
| 1M (21D) | 7.2% | -1.6% |
| 3M (63D) | 32.7% | 4.4% |
| YTD 2025 | 17.7% | 15.0% |
| 2024 | -2.7% | 23.3% |
| 2023 | -6.4% | 24.2% |
| 2022 | -5.5% | -19.4% |
However, big gains can follow sharp reversals – but how has A behaved after prior drops? See A Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 181 S&P constituents with 3 days or more of consecutive gains and 3 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 142 | 1 |
| 4D | 25 | 0 |
| 5D | 6 | 1 |
| 6D | 5 | 0 |
| 7D or more | 3 | 1 |
| Total >=3 D | 181 | 3 |
Key Financials for Agilent Technologies (A)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $6.8 Bil | $6.5 Bil |
| Operating Income | $1.4 Bil | $1.5 Bil |
| Net Income | $1.2 Bil | $1.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $1.7 Bil | $1.7 Bil |
| Operating Income | $300.0 Mil | $360.0 Mil |
| Net Income | $215.0 Mil | $336.0 Mil |
While A stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.